Kastritis, E. Gavriatopoulou, M. Kyrtsonis, M.-C. Roussou, M. Hadjiharissi, E. Symeonidis, A. Repoussis, P. Michalis, E. Delimpasi, S. Tsatalas, K. Tsirigotis, P. Vassou, A. Vervessou, E. Katodritou, E. Gika, D. Terpos, E. Dimopoulos, M.A., Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: Final analysis of a phase 2 study, Blood advances, (126), 1392-1394, 2015, American Society of Hematology,